Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 9/20 | 0.51 |
| ▸ | BCHE | P06276 | 8/20 | 0.51 |
| ▸ | BACE1 | P56817 | 8/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CCR3 | P51677 | 1/20 | 0.46 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.46 |
| ▸ | DRD2 | P14416 | 1/20 | 0.44 |
| ▸ | DRD4 | P21917 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3784554 | 0.89 | SIGMAR1 (0.50) | ACHEBCHEBACE1SIGMAR1CYP1A2 | |
| SCHEMBL3774505 | 0.89 | ACHE (0.55) | ACHEBCHEBACE1SIGMAR1CYP1A2 | |
| SCHEMBL6217555 | 0.89 | ACHE (0.55) | ACHEBCHEBACE1SIGMAR1CYP1A2 | |
| SCHEMBL3781490 | 0.89 | ACHE (0.55) | ACHEBCHEBACE1SIGMAR1CYP1A2 | |
| SCHEMBL928351 | 0.89 | SIGMAR1 (0.50) | ACHEBCHEBACE1SIGMAR1CYP1A2 | |
| SCHEMBL3777655 | 0.89 | SIGMAR1 (0.50) | ACHEBCHEBACE1SIGMAR1CYP1A2 | |
| SCHEMBL6640228 | 0.89 | ACHE (0.55) | ACHEBCHEBACE1SIGMAR1CYP1A2 | |
| Hydrochloric Acid SCHEMBL3650275 | 0.88 | ACHE (0.54) | ACHEBCHEBACE1SIGMAR1CYP1A2 | |
| Hydrochloric Acid SCHEMBL3650271 | 0.88 | ACHE (0.54) | ACHEBCHEBACE1SIGMAR1CYP1A2 | |
| SCHEMBL3352682 | 0.86 | SIGMAR1 (0.68) | ACHEBCHEBACE1SIGMAR1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140275017-A1 | CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME CORP. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140275017-A1 | CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME CORP. (US) | 2014-09-18 | — | — | US | disclosed |
| US-8778957-B2 | CGRP receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2014-07-15 | — | — | US | disclosed |
| US-8778957-B2 | CGRP receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2014-07-15 | — | — | US | disclosed |
| US-20120010193-A1 | CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME CORP. (US) | 2012-01-12 | — | — | US | disclosed |
| US-20120010193-A1 | CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME CORP. (US) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140275017-A1 | CGRP RECEPTOR ANTAGONISTS | BDKRB1, CALCRL, BDKRB2 | ACHE 735/4885BCHE 1607/4885BACE1 580/4885 |
| US-20120010193-A1 | CGRP RECEPTOR ANTAGONISTS | BDKRB1, BDKRB2, CALCRL | ACHE 759/4885BCHE 1463/4885BACE1 573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.